Physician profile
June Losurdo
NPI 1003096918
$9,099.52
in general payments reported to CMS, 2019-2025
13 companies · $4,834 in 2025
The $4,834 reported for 2025 was more than what 99% of Gerontology (Nurse Practitioner) providers received nationally (typical 2025 total: $180).
See the full distribution for Gerontology (Nurse Practitioner)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $331 · 2022: $62.87 · 2023: $1,661 · 2024: $2,211 · 2025: $4,834.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $3,422 · Food and Beverage: $2,682 · Consulting Fee: $2,600 · Education: $2.00.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $3,421.65 |
| Food and Beverage | $2,681.93 |
| Consulting Fee | $2,600.00 |
| Education | $2.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Edwards Lifesciences Corporation | $7,833.98 | 2021-2025 | Edwards Sapien 3 Ultra Transcatheter Heart Valve, Edwards Sapien 3 Transcatheter Heart Valve (Thv), Sapien 3 Ultra Resilia |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $362.69 | 2022-2025 | Lifevest |
| Boehringer Ingelheim Pharmaceuticals, INC. | $311.69 | 2021-2025 | Jardiance |
| Boston Scientific Corporation | $176.54 | 2024-2025 | Watchman Access System, Watchman Flx |
| Heartflow, INC. | $99.99 | 2025 | |
| Shockwave Medical, INC | $77.40 | 2023 | Shockwave Ivl System With The Shockwave C2 Coronary Ivl Catheter |
| Amgen INC. | $68.63 | 2023-2024 | Repatha |
| Abbott Laboratories | $55.98 | 2023-2024 | Cardiomems |
| Novartis Pharmaceuticals Corporation | $44.97 | 2024-2025 | |
| Pfizer INC. | $23.13 | 2025 | |
| Cordis US Corp. | $18.38 | 2022 | |
| Esperion Therapeutics, INC. | $14.01 | 2024 | Nexletol |
| Astrazeneca Pharmaceuticals LP | $12.13 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw June Losurdo listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.